S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
S&P 500   4,551.68
DOW   35,490.69
QQQ   380.00
NASDAQ:INO

Inovio Pharmaceuticals Short Interest Ratio and Short Volume

$6.79
-0.05 (-0.73 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.77
$6.98
50-Day Range
$6.36
$9.69
52-Week Range
$5.81
$19.00
Volume
2.04 million shs
Average Volume
8.49 million shs
Market Capitalization
$1.43 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.62

Inovio Pharmaceuticals (NASDAQ:INO) Short Interest Data

Current Short Volume
46,000,000 shares
Previous Short Volume
45,210,000 shares
Change Vs. Previous Month
+1.75%
Dollar Volume Sold Short
$322.92 million
Short Interest Ratio / Days to Cover
11.2
Last Record Date
October, 15 2021
Outstanding Shares
210,357,000 shares
Float Size
206,890,000 shares
Short Percent of Float
22.23%
Today's Trading Volume
2,042,919 shares
Average Trading Volume
8,490,361 shares
Today's Volume Vs. Average
-75.94%
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Inovio Pharmaceuticals ?

Sign up to receive the latest short interest report for Inovio Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Inovio Pharmaceuticals (NASDAQ:INO) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202146,000,000 shares $322.92 million +1.8%22.2%11.2 $7.02
9/30/202145,210,000 shares $323.70 million +1.7%21.9%10.4 $7.16
9/15/202144,450,000 shares $336.49 million +2.1%21.5%9.8 $7.57
8/31/202143,540,000 shares $376.19 million +2.3%21.1%9.3 $8.64
8/13/202142,570,000 shares $392.92 million -1.9%20.6%8.6 $9.23
7/30/202143,390,000 shares $364.48 million -4.6%21.2%8.3 $8.40
7/15/202145,500,000 shares $364 million +2.0%22.2%7 $8.00
6/30/202144,590,000 shares $413.35 million -4.6%21.8%5.7 $9.27
6/15/202146,740,000 shares $403.37 million -8.2%22.8%5.8 $8.63
5/28/202150,940,000 shares $384.60 million -9.1%24.9%5.9 $7.55
5/14/202156,010,000 shares $348.94 million +2.9%N/A5.7 $6.23
4/30/202154,460,000 shares $375.23 million +5.9%N/A4.8 $6.89
4/15/202151,430,000 shares $454.64 million -5.9%N/A3.3 $8.84
3/31/202154,640,000 shares $481.38 million -4.4%N/A3.9 $8.81
3/15/202157,170,000 shares $600.29 million +13.8%N/A3.8 $10.50
2/26/202150,230,000 shares $577.14 million +16.6%N/A3.2 $11.49
2/12/202143,090,000 shares $560.17 million -0.5%N/A2.8 $13.00
1/29/202143,310,000 shares $474.24 million -22.8%N/A2.8 $10.95
1/15/202156,070,000 shares $525.38 million -0.1%N/A4.7 $9.37
12/31/202056,140,000 shares $505.26 million +6.8%N/A5.5 $9.00
12/15/202052,560,000 shares $547.15 million -5.1%N/A4.6 $10.41
11/30/202055,370,000 shares $678.84 million -6.3%N/A3.4 $12.26
11/15/202059,080,000 shares $662.88 million +4.1%N/A3.7 $11.22
10/30/202056,760,000 shares $595.41 million +3.1%N/A3.5 $10.49
10/15/202055,040,000 shares $667.64 million -3.9%N/A3 $12.13

Institutional Investors Shorting Inovio Pharmaceuticals (NASDAQ:INO)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of Inovio Pharmaceuticals. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
8/31/2021Pathstone Family Office LLCN/A16,101N/A$149.00
8/20/2021Jefferies Group LLC50,3000-100.0%$0.00
8/17/2021Walleye Trading LLCN/A20,700N/A$192.00
8/17/2021Pathstone Family Office LLCN/A16,101N/A$149.00
8/17/2021Aristides Capital LLC76,6000-100.0%$0.00
8/17/2021Citadel Advisors LLC1,006,500537,900-46.6%$4,986.00
8/16/2021Bank of America Corp DE251,000159,300-36.5%$1,477.00
8/16/2021Jefferies Group LLC50,3000-100.0%$0.00
8/12/2021Simplex Trading LLC2,0190-100.0%$0.00
8/12/2021Bank of Montreal Can108,1000-100.0%$0.00
8/11/2021HAP Trading LLC62,900146,300+132.6%$141.00
8/11/2021Susquehanna International Group LLP1,227,5001,394,300+13.6%$12,925.00
8/6/2021Wolverine Trading LLC142,700142,000-0.5%$1,343.00
8/6/2021IMC Chicago LLC391,3000-100.0%$0.00
7/31/2021Cutler Group LP3,2004,200+31.3%$134.00













Inovio Pharmaceuticals (NASDAQ:INO) Short Interest Frequently Asked Questions

What is Inovio Pharmaceuticals' current short interest?

Short interest is the volume of Inovio Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 46,000,000 shares of INO short. 22.23% of Inovio Pharmaceuticals' shares are currently sold short. Learn More on Inovio Pharmaceuticals' current short interest.

What is a good short interest ratio for Inovio Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Inovio Pharmaceuticals currently has a short interest ratio of 11.0. Learn More on a good short interest ratio for Inovio Pharmaceuticals

Which institutional investors are shorting Inovio Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Inovio Pharmaceuticals: Pathstone Family Office LLC, Jefferies Group LLC, Walleye Trading LLC, Pathstone Family Office LLC, Aristides Capital LLC, Citadel Advisors LLC, Bank of America Corp DE, Jefferies Group LLC, Simplex Trading LLC, Bank of Montreal Can, HAP Trading LLC, Susquehanna International Group LLP, Wolverine Trading LLC, IMC Chicago LLC, and Cutler Group LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Inovio Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.23% of Inovio Pharmaceuticals' floating shares are currently sold short.

Is Inovio Pharmaceuticals' short interest increasing or decreasing?

Inovio Pharmaceuticals saw a increase in short interest in October. As of October 15th, there was short interest totaling 46,000,000 shares, an increase of 1.7% from the previous total of 45,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Inovio Pharmaceuticals' float size?

Inovio Pharmaceuticals currently has issued a total of 210,357,000 shares. Some of Inovio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Inovio Pharmaceuticals currently has a public float of 206,890,000 shares.

How does Inovio Pharmaceuticals' short interest compare to its competitors?

22.23% of Inovio Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Inovio Pharmaceuticals: ICU Medical, Inc. (2.40%), Inari Medical, Inc. (4.50%), Nevro Corp. (7.23%), Merit Medical Systems, Inc. (2.85%), Haemonetics Co. (3.80%), AtriCure, Inc. (2.17%), Axonics, Inc. (12.71%), The Beauty Health Company (20.00%), NuVasive, Inc. (7.82%), and Silk Road Medical, Inc (6.61%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.75 billion), S&P Global Inc. ($7.73 billion), Charter Communications, Inc. ($5.40 billion), Snowflake Inc. ($4.50 billion), Canadian Pacific Railway Limited ($4.39 billion), Uber Technologies, Inc. ($4.21 billion), Wayfair Inc. ($4.15 billion), Palo Alto Networks, Inc. ($3.27 billion), Teladoc Health, Inc. ($2.78 billion), and DoorDash, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Inovio Pharmaceuticals stock?

Short selling INO is an investing strategy that aims to generate trading profit from Inovio Pharmaceuticals as its price is falling. Inovio Pharmaceuticals' stock is trading down $0.05 today. To short Inovio Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Inovio Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Inovio Pharmaceuticals?

A short squeeze for Inovio Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INO, which in turn drives the price of the stock up even further.

How often is Inovio Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INO, twice per month. The most recent reporting period available is October, 15 2021.



This page was last updated on 10/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.